Clinical trial
Buspirone in Reducing Shortness of Breath in Patients With Cancer
NCT00053846 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00053846 |
|---|---|
| Title | Buspirone in Reducing Shortness of Breath in Patients With Cancer |
| Official title | Buspirone in Reducing Shortness of Breath in Patients With Cancer |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Dyspnea, Pulmonary Complications, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | buspirone hydrochloride, Placebo |
| Enrollment | 432 |
| Start date | Nov 1, 2002 |
| Primary completion | Nov 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | Feb 6, 2003 |
| Last update posted | Nov 24, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: